1MK Stock Overview
A medical device company, manufactures and sells medical devices in Europe and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Mauna Kea Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.067 |
| 52 Week High | €0.46 |
| 52 Week Low | €0.042 |
| Beta | 1.33 |
| 1 Month Change | 2.46% |
| 3 Month Change | -55.83% |
| 1 Year Change | -81.97% |
| 3 Year Change | -85.93% |
| 5 Year Change | -94.67% |
| Change since IPO | -97.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1MK | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 35.0% | 1.5% | 2.5% |
| 1Y | -82.0% | -11.3% | 14.4% |
Return vs Industry: 1MK underperformed the German Medical Equipment industry which returned -10.3% over the past year.
Return vs Market: 1MK underperformed the German Market which returned 14.9% over the past year.
Price Volatility
| 1MK volatility | |
|---|---|
| 1MK Average Weekly Movement | 37.2% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: 1MK's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 1MK's weekly volatility has increased from 24% to 37% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 65 | Sacha Loiseau | www.maunakeatech.com |
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
Mauna Kea Technologies SA Fundamentals Summary
| 1MK fundamental statistics | |
|---|---|
| Market cap | €6.01m |
| Earnings (TTM) | -€10.40m |
| Revenue (TTM) | €8.42m |
0.7x
P/S Ratio-0.6x
P/E RatioIs 1MK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1MK income statement (TTM) | |
|---|---|
| Revenue | €8.42m |
| Cost of Revenue | €1.22m |
| Gross Profit | €7.20m |
| Other Expenses | €17.60m |
| Earnings | -€10.40m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Oct 02, 2025
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 85.56% |
| Net Profit Margin | -123.64% |
| Debt/Equity Ratio | -140.0% |
How did 1MK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/05 06:21 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mauna Kea Technologies SA is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Guillaume Cuvillier | Gilbert Dupont |
| Stephanie Lefebvre | Gilbert Dupont |
| Sachin Soni | Kempen & Co. NV |